BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/2/2015 12:22:00 PM | Browse: 1485 | Download: 1430
Publication Name World Journal of Hepatology
Manuscript ID 9392
Country Italy
ISSN 1948-5182 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Pharmacology & Pharmacy
Manuscript Type Systematic Reviews
Article Title Assessing liver injury associated with antimycotics: Concise literature review and clues from data mining of the FAERS database
Manuscript Source Invited Manuscript
All Author List Emanuel Raschi, Elisabetta Poluzzi, Ariola Koci, Paolo Caraceni and Fabrizio De Ponti
Funding Agency and Grant Number
Corresponding Author Fabrizio De Ponti, MD, PhD, Pharmacology Unit, Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Via Irnerio, 48, I-40126 Bologna BO, Italy. fabrizio.deponti@unibo.it
Key Words Drug-induced hepatotoxicity; Antimycotics; Drug safety; Pharmacovigilance; Spontaneous reporting systems
Core Tip The recent regulatory interventions (United States restriction and Europe suspension) concerning ketoconazole for drug-induced liver injury (DILI) poses a prescribing challenge to clinicians, who should now carefully consider safer therapeutic alternatives. Data mining of FAERS database (2004-2011) highlighted that: (1) antimycotics are involved in approximately 3% of DILI cases (including acute liver failure events); (2) virtually all systemic antimycotics (e.g., azole derivatives), are associated with disproportionality signals; careful monitoring is therefore recommended, especially in critical poly-treated patients with multiple comorbidities; and (3) topical antimycotics, as expected, do not generate a post-marketing signal of DILI, thus indicating the accuracy of our approach.Data mining of FAERS database (2004-2011) highlighted that: (a) antimycotics are involved in approximately 3% of DILI cases (including acute liver failure events); (b) virtually all systemic antimycotics (e.g., azole derivatives), are associated with disproportionality signals; careful monitoring is therefore recommended, especially in critical poly-treated patients with multiple comorbidities; (c) topical antimycotics, as expected, do not generate a post-marketing signal of DILI, thus indicating the accuracy of our approach.
Publish Date 2014-08-29 07:54
Citation Raschi E, Poluzzi E, Koci A, Caraceni P, De Ponti F. Assessing liver injury associated with antimycotics: Concise literature review and clues from data mining of the FAERS database. World J Hepatol 2014; 6(8): 601-612
URL http://www.wjgnet.com/1948-5182/full/v6/i8/601.htm
DOI http://dx.doi.org/10.4254/wjh.v6.i8.601
Full Article (PDF) WJH-6-601.pdf
Full Article (Word) WJH-6-601.doc